Chapter 34 Treatment of Seizure Disorders
Abbreviations | |
---|---|
EEG | Electroencephalogram |
GABA | γ-Aminobutyric acid |
NMDA | N-methyl-D-aspartate |
Therapeutic Overview
Therapeutic Overview |
---|
Partial (Focal) Seizures |
Simple seizures |
No loss of consciousness, may or may nor be preceded by an aura, includes sensory, motor, autonomic, or psychic features |
Complex seizures |
Impaired consciousness, dreamy dysaffective state with or without automatisms |
Secondarily generalized tonic-clonic seizures |
Evolves from simple or complex partial seizure, impaired consciousness with rigid extension of trunk and limbs (tonic phase) and rhythmic contractions of arms and legs (clonic phase) |
Generalized Seizures |
Tonic-clonic (grand mal) seizures |
As above for partial with secondarily generalized tonic-clonic seizures |
Absence seizures |
Abrupt loss of consciousness with staring and cessation of ongoing activity with or without eye blinks |
Other types of seizures |
Myoclonic—sporadic, isolated jerking movements |
Clonic—repetitive jerking movements |
Tonic—muscle stiffness and rigidity |
Atonic (atypical)—loss of muscle tone |
of familial epilepsy. The causes of isolated seizures and epilepsy (recurrent seizures) are summarized in Box 34-1.
BOX 34–1 Causes of Seizures
Mechanisms of Action
Antiepileptic drugs have been classified and selected for many years based on seizure type (Box 34-2). Although the intricate cellular alterations in the neuronal events mediating the generation of seizures is not totally understood, studies have provided evidence of likely alterations involved in both partial seizures and absence seizures to enable a mechanistic-based approach for treatment.
Partial seizures are thought to develop as a consequence of the loss of surround inhibition, a process that normally prevents the activation of neurons adjacent to a focus (Fig. 34-1). This loss of surround inhibition may result from impaired γ-aminobutyric acid (GABA) transmission, alterations in dendritic structure, changes in voltage-gated ion channel activity or density, or alterations in intracellular ion concentrations. If the seizure generalizes secondarily to involve both hemispheres, tonic-clonic effects are manifest. The tonic phase of muscle contraction is thought to reflect prolonged neuronal depolarization as a consequence of the loss of GABA-mediated inhibition and dominance of excitatory glutamate transmission. As the seizure evolves, neurons repolarize and afterhyperpolarizations are apparent, which reflect the reappearance of GABA-mediated inhibition and diminished glutamate excitation, producing the clonic phase. Thus drugs that increase surround inhibition and prevent the spread of synchronous activity are used for the treatment of partial seizures.
Our understanding of the onset of generalized tonic-clonic seizures is limited. However, there are some clues concerning the cellular mechanisms underlying absence seizures, which are characterized by the sudden appearance of spike-wave discharges synchronized throughout the brain. The EEGs recorded during an absence seizure compared with a generalized tonic-clonic seizure are shown in Figure 34-2. Studies support a major role of thalamocortical circuits in the pathogenesis of absence seizures with abnormal oscillations between cortical and thalamic neurons. The circuit involves excitatory glutamatergic cortical pyramidal and thalamic relay neurons and inhibitory GABAergic thalamic reticular neurons (Fig. 34-3). Thalamic relay neurons exhibit spike-wave discharges that generate normal cortical rhythms and participate in the generation of sleep spindles. The normal bursting pattern of these neurons results from the activation (depolarization) of low voltage-gated T-type (transient inward current) Ca++ channels, followed by hyperpolarization mediated by GABA released from thalamic reticular neurons. Thus drugs that block these T-type Ca++ currents are effective for the treatment of absence seizures.
Agents used for the treatment of epilepsy depress aberrant neuronal firing by primarily altering ion channel activity, enhancing GABA-mediated inhibitory neurotransmission, or dampening glutamate-mediated excitatory neurotransmission. It is important to note that although some drugs have a single mechanism of action, several of these agents have more than one mechanism. Anticonvulsant drugs classified according to mechanisms of action are listed in Box 34-3.
The voltage-gated Na+ channel blockers are widely used antiseizure drugs with demonstrated effectiveness for partial and secondarily generalized seizures. These drugs include phenytoin, carbamazepine, oxcarbazepine, lamotrigine, topiramate, valproic acid, and zonisamide. These agents reduce the repetitive firing of neurons by producing a use-dependent blockade of Na+ channels (Fig. 34-4). By prolonging the inactivated state of the Na+ channel and thus the relative refractory period, these drugs do not alter the first action potential but rather reduce the likelihood of repetitive action potentials. Neurons retain their ability to generate action potentials at the lower frequencies common during normal brain function. Because these drugs block repetitive firing, they are better at controlling partial and tonic-clonic seizures than absence seizures.
As indicated, T-type Ca++ currents